National Institute of Allergy and Infectious Diseases: Biomedical STI Prevention Evidence Is Inadequate for Cisgender Women
December 21, 2023
December 21, 2023
WASHINGTON, Dec. 21 (TNSres) -- The U.S. Department of Health and Human Services' National Institute of Allergy and Infectious Diseases issued the following news release:
* * *
NIH Leadership Calls for Population-Specific Considerations in Study Design
* * *
Pivotal studies of some biomedical HIV and sexually transmitted infection (STI) prevention interventions have excluded cisgender women or demonstrated low efficacy among them, limiting . . .
* * *
NIH Leadership Calls for Population-Specific Considerations in Study Design
* * *
Pivotal studies of some biomedical HIV and sexually transmitted infection (STI) prevention interventions have excluded cisgender women or demonstrated low efficacy among them, limiting . . .